FDA approves drug for patients receiving MECFebruary 5, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaPharmacyRelated Issues
Generic imatinib launched with savings programFebruary 4, 2016CythemiasAnemiaLeukemia, Myelodysplasia, TransplantationPediatricsPharmacyALLMyelodysplastic Syndrome
EHA creates ‘roadmap’ for hematology researchFebruary 3, 2016CythemiasAnemiaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaThrombosisBlood Banking
Drug nets 3rd breakthrough designation from FDAJanuary 29, 2016Leukemia, Myelodysplasia, TransplantationPharmacyAML
Drug granted another breakthrough designation for CLLJanuary 21, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
Drug approved to treat ALL in EUJanuary 20, 2016Leukemia, Myelodysplasia, TransplantationPediatricsPharmacyALL
FDA approves maintenance therapy for CLLJanuary 20, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma